ArticleFrontiers in cell and developmental biology2022

Olaparib, a PARP-1 inhibitor, protects retinal cells from ocular hypertension-associated oxidative damage.

Yuting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.